REYATAZ
- Product NDC
- 70518-0469
- 11-digit product format
- 705180469
- Labeler code
- 70518
- Product ID
- 70518-0469_852991f4-f5c6-6e10-e053-2991aa0a1673
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATAZANAVIR
- Dosage form
- CAPSULE, GELATIN COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA021567
- Marketing category
- NDA
- Marketing start
- 2017-04-28
- Marketing end
- 0000-00-00
- Substance
- ATAZANAVIR SULFATE
- Active strength
- 300 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record